Detected
OPTHNasdaq Trader
Optimi Health Corp. to begin Nasdaq trading after 1-for-30 reverse split
Listing RiskvolatileImpact78
OPTH Price
Stored market data$4.75$0.00 (-0.32%)
Why It Matters
Holders will have reduced share counts (possible fractional cash‑outs), trade on a different venue and price level, and face unknown dilution from the offering.
Optimi Health will effect a one‑for‑thirty reverse split and uplist from the OTC market to the Nasdaq Capital Market, expected May 20, 2026. The uplist is conditional on a concurrent public offering, which creates potential dilution; current holders will see consolidated holdings and venue change.
Score78
Score Rationale
volatileReverse split and uplist materially change tradability and introduce unknown offering dilution.
Bullish
- Uplist to Nasdaq typically improves visibility and broker access.
- Nasdaq listing can broaden buyer base and potential liquidity.
- Public offering could provide operating capital if proceeds used productively.
Bearish
- Public offering will dilute existing holders; terms are unspecified.
- One‑for‑30 reverse split signals low pre‑split price and can be negative signal.
- Fractional shares from the split may be cashed out by brokers.
Key Evidence
- Notice: expected Nasdaq Capital Market listing May 20, 2026.
- Corporate action: one‑for‑thirty (1-30) reverse split.
- Listing is conditional on effectiveness of reverse split and an offering.
What To Watch Next
- SEC filing or prospectus describing offering size and price.
- Broker communications about fractional-share treatment post-split.
- Confirmation of effective split and Nasdaq first trade.
- Dilution math: new shares issued and post-offering share count.